951174-11-1Relevant articles and documents
N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties
Zajdel, Pawe?,Marciniec, Krzysztof,Sata?a, Grzegorz,Canale, Vittorio,Kos, Tomasz,Partyka, Anna,Jastrz?bska-Wi?sek, Magdalena,Weso?owska, Anna,Basińska-Ziobroń, Agnieszka,Wójcikowski, Jacek,Daniel, W?adys?awa A.,Bojarski, Andrzej J.,Popik, Piotr
, p. 618 - 622 (2016/07/06)
A series of N1-azinylsulfonyl-3-(1,2,3,6,tetrahyrdopyridin-4-yl)-1H-indole derivatives was designed to obtain highly potent 5-HT6 receptor ligands. The study allowed for the identification of 25 (4-{[5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-1-yl]sulfonyl}isoquinoline), a potent and selective 5-HT6 receptor antagonist. The selected compound, was evaluated in vivo in a novel object recognition (NOR) and forced swim (FST) tests in rats, demonstrating distinct pro-cognitive and antidepressant-like properties (MED = 1 mg/kg and 0.1 mg/kg, i.p., respectively). Compound SB-742457, used as comparator, reversed memory deficits in NOR task in similar doses, while in FST it was active in 10-30-fold higher dose (3 mg/kg). In contrast to SB-742457, which was active in Vogel test (MED = 3 mg/kg), compound 25 displayed no anxiolytic activity.
Substituted heterocyclic compounds and its application on the medicament (by machine translation)
-
Paragraph 0196; 0197; 0198; 0199; 0219; 0220; 0221; 0222, (2017/06/02)
The invention relates to substituted heterocyclic compounds and its application on the medicament, in particular to a novel class of substituted heterocyclic compounds or its isomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug, and their method of preparation. The invention also relates to the compounds of the invention pharmaceutical composition, and said compound or pharmaceutical compositions for the treatment5-HT6receptor-related diseases, in particular Alzheimer's disease in the use thereof. (by machine translation)